Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

NCT02581553 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ardea Biosciences, Inc.